eli lilly glp-1 drug to seek approval of new weight-loss this year Lilly is selling $12.9 billion
Description
Semaglutide (Ozempic, Wegovy, Rybelsus) : Available as once-weekly injection (0.52.0 mg for diabetes
Increases in amylase and lipase levels were also observed but were asymptomatic, with one exception: a single case of acute pancreatitis that was classified as a serious adverse event
Prasad-Reddy, L
When these problems occur theyre hard to overlook
Document your current dose, how long you have been at that dose, your total weight loss to date, and any ongoing side effects
